Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Component of the AP-1 transcription factor that represses transactivation mediated by the Jun family of proteins. Additionally we are shipping JDP2 Proteins (8) and JDP2 Kits (3) and many more products for this protein.
Showing 10 out of 19 products:
Human Polyclonal JDP2 Primary Antibody for ELISA, WB - ABIN1450713
Heilig, Eckenberg, Petit, Fonknechten, Da Silva, Cattolico, Levy, Barbe, de Berardinis, Ureta-Vidal, Pelletier, Vico, Anthouard, Rowen, Madan, Qin, Sun, Du, Pepin, Artiguenave, Robert, Cruaud, Brüls et al.: The DNA sequence and analysis of human chromosome 14. ... in Nature 2003
Preeclamptic plasma induces transcription modifications involving the AP-1 (show FOSB Antibodies) transcriptional regulator JDP2 in endothelial cells.
Results suggest that JDP2 is an integral component of the Nrf2-MafK complex and that it modulates antioxidant and detoxification programs by acting via the ARE.
the recruitment of multiple HDAC (show HDAC3 Antibodies) members to JDP2 and ATF3 (show ATF3 Antibodies) is part of their transcription repression mechanism.
The molecular mechanisms that underlie the action of JDP2 in cellular aging and replicative senescence by mediating the dissociation of polycomb (show CBX2 Antibodies) repressive complexes from the p16(Ink4a)/Arf (show CDKN2A Antibodies) locus are discussed.
JDP2 is crucial to triggering reactivation from latency to lytic replication
JDP2 expression was downregulated in pancreatic carcinoma & this correlated with metastasis & decreased post-surgery survival.
c-Jun dimerization protein 2 inhibits cell transformation and has a role as a tumor suppressor gene
JDP2 is a cellular survival protein whose presence is necessary for normal cellular function
JDP2 acts as a repressor and could be functionally associated with HDAC3 (show HDAC3 Antibodies) to inhibit CHOP (show DDIT3 Antibodies) transcription
IRF2 (show IRF2 Antibodies)-BP1 (show DLX4 Antibodies) is a JDP2-binding protein enhancing the polyubiquitination of JDP2 and represses ATF2 (show ATF2 Antibodies)-mediated transcriptional activation from a CRE-containing promoter.
High JDP2 expression in the bone marrow contributes to metastatic spread in the lung.
results suggest a negative feedback loop between JDP2 and p53 (show TP53 Antibodies), and a direct link between JDP2 and a key oncogenic pathway
Tbx3 (show TBX3 Antibodies) plays an important role in osteoclastogenesis at least in part by regulating CSF1 (show CSF1 Antibodies)-dependent expression of JDP2.
Using transgenic mice overexpressing the AP-1 (show JUN Antibodies) inhibitor JDP2, a central role of AP-1 (show JUN Antibodies) in the induction of hypertrophy and apoptosis in cardiomyocytes is demonstrated.
Jdp2 transcriptionally regulates the Trp53 (show TP53 Antibodies) promoter, via an atypical AP-1 (show JUN Antibodies) site, and Jdp2 expression negatively regulates Trp53 (show TP53 Antibodies) expression levels; a genetic mechanism for tumour formation in the context of Trp53 (show TP53 Antibodies) heterozygosity
Jdp2 plays pivotal roles in in vivo bone homeostasis and host defense by regulating osteoclast and neutrophil differentiation.
JDP2 phosphorylation by JNK (show MAPK8 Antibodies) results in rapid JDP2 destabilization and reduced expression levels following various cell stimuli
transcription of the gene for cyclin-A2 (show CCNA2 Antibodies) appears to be a direct target of JDP2 in the suppression of cell proliferation
JDP2 expression may play a critical role in liver cancer development.
the kinase fragment of DCLK (show DCLK2 Antibodies) is translocated into the nucleus upon hyperosmotic stresses and the kinase efficiently phosphorylates JDP2, a possible target in the nucleus, with the aid of histones
Component of the AP-1 transcription factor that represses transactivation mediated by the Jun family of proteins. Involved in a variety of transcriptional responses associated with AP-1 such as UV-induced apoptosis, cell differentiation, tumorigenesis and antitumogeneris. Can also function as a repressor by recruiting histone deacetylase 3/HDAC3 to the promoter region of JUN. May control transcription via direct regulation of the modification of histones and the assembly of chromatin.
Jun dimerization protein 2
, jun dimerization protein 2
, progesterone receptor co-activator
, c-Jun dimerization protein 2